PanamaTimes

Wednesday, Feb 05, 2025

Withholding vaccine safety data ‘morally indefensible,’ medical journal says

Withholding vaccine safety data ‘morally indefensible,’ medical journal says

The British Medical Journal criticized Covid-19 vaccine manufacturers for ‘reaping vast profits’ without proper independent scrutiny

The British Medical Journal (BMJ) has urged public health regulators and pharma majors to immediately release all raw data from Covid-19 vaccine trials for independent scrutiny, arguing that “complete data transparency” was a matter of “public interest.”

Branding Big Pharma as “the least trusted industry,” a recent op-ed by BMJ editors stated that it was “morally indefensible” that this information remains inaccessible to doctors, researchers and the public, despite the global rollout of vaccines and treatments.

In the scathing editorial, the writers – senior BMJ editor Peter Doshi, former editor-in-chief Fiona Godlee and her successor Kamran Abbasi – accuse pharmaceutical companies of “reaping vast profits without adequate independent scrutiny of their scientific claims.”

"At least three of the many companies making Covid-19 vaccines have past criminal and civil settlements costing them billions of dollars. One pleaded guilty to fraud. Other companies have no pre-Covid track record."


In particular, the editorial collective calls out Pfizer, Moderna and AstraZeneca for not providing “timely access” to “anonymized individual participant data” from their clinical trials. This granular data is available to regulators like the US Food and Drug Administration (FDA), which told a judge last month to give it 75 years to publish all data relating to the Pfizer-BioNTech vaccine.

But the BMJ said Pfizer – whose trial was “funded by the company and designed, run, analyzed, and authored by Pfizer employees” – has indicated that it will not entertain data requests until May 2025, a full two years after the primary study is completed.

This lack of access to data is “consistent across vaccine manufacturers,” the editors write, noting that the industry is not “legally required” to honor requests from independent researchers.

Further, they point out that regulatory bodies like Health Canada and the European Medicines Agency do not even “receive or analyze” trial data, whereas the UK’s Medicines and Healthcare Products Regulatory Agency does not “proactively release” such info.

“The purpose of regulators is not to dance to the tune of rich global corporations and enrich them further; it is to protect the health of their populations,” they concluded.

Comments

MHogan 3 year ago
The skeptic in me believes that any negative data — safety or otherwise — released by the FDA or Pharma will have been manipulated beyond recognition from the truth.
mike 3 year ago
The pharmafia works exclusively for Dagobert Duck. People's health doesn't matter.
Maybe omicron will stop this nonsense.

Newsletter

Related Articles

PanamaTimes
0:00
0:00
Close
The Trump administration is considering El Salvador's proposal to accommodate U.S. prisoners.
Trump Wins Again as Canada Agrees to Strengthen Border Security
Wall Street Journal Criticizes Trump's Trade War with Canada and Mexico
Trump Freezes Tariffs on Mexico After Agreement on Border Security
Nearly 96% of New Cars Registered in Norway in January Were Electric
Marco Rubio Urges Panama to Limit Chinese Influence Amid Canal Dispute
Apple Surpasses Revenue and Earnings Expectations, But iPhone Sales Disappoint
Bill Gates Reflects on Past Mistakes and Acknowledges Yuval Noah Harari's Insight
Trump Imposes Emergency Tariffs on Colombia Following Immigration Dispute
Musk and X Intensify Legal Battle Over Advertising Boycott, Suing Nestlé, LEGO, and Shell
Trump: Canada Should Become the 51st U.S. State
U.S. President Trump Asserts Intent to Reclaim Panama Canal Amid Rising Geopolitical Tensions
Panama Rules Out Negotiations With US Over Control of Canal
The 'Chinese Pearl Harbor' on U.S. Tech: DeepSeek's Launch Triggers Market Collapse
Key Takeaways from the 2025 World Economic Forum in Davos
The Trump Era 2: A Time of Dramatic and Profound Change
Five Billionaires on Track to Break One Trillion Dollar Wealth Barrier
Bill Ackman Praises Social Media Platform X as 'The New Media'
California Wildfires Set to Become Costliest in U.S. History
Chief Justice Roberts Warns Against Threats to Judicial Independence
Generation Z Faces Scrutiny Over Workplace Readiness
Democrats Call on Biden to Protect Controversial Temporary Protected Status Program
Trinidad and Tobago Declares State of Emergency as Murder Rates Surge
Migrant Children Abandoned at U.S.-Mexico Border
The Closure of the Global Engagement Center: Controversy, Claims, and Conclusions
The American Democrats Party Strives to Rise from the Ashes
Trump Nominates Kevin Marino Cabrera as Ambassador to Panama Amid Canal Dispute
Texas Congresswoman Kay Granger Located in Nursing Home Following Six Months of Inactivity
A large group of unauthorized migrants is traveling through Mexico with the aim of reaching the USA before Trump assumes office.
A Democrat Congresswoman with blue and black hair is having a breakdown over "President Musk."
Argentina Defies Predictions with Record $17 Billion Trade Surplus, But Is the Growth Sustainable?
Disney's High Seas Gamble: Navigating the Waters of Cruise Expansion
The Surprising Impact of Extreme Heat on Mexico's Youth
Polarization: The Word That Unites a Divided Era
Exoneration in the Subway: The Complexities of Self-Defense and Public Safety
The Tragic Passing of UnitedHealthcare CEO Highlights Corporate Security Challenges
Global Developments: Violence in Sinaloa, Political Chaos in the Bahamas, Venezuelan Voting Disputes, and a Major UK Drug Bust
OpenAI and Anduril: Charting AI's Path in Modern Warfare
The Pardon of Hunter Biden: A Symbol of Hypocrisy
Biden Crafted the Strategy Used by Trump
South Korea's Democracy Tested: President Yoon’s Martial Law Reversal Sparks Political Reckoning
Seoul Crisis: Yoon Suk Yeol's Martial Law Blunder Triggers Political Upheaval
Generative AI's Limited Impact on Elections Highlighted by Meta
France at the Precipice: Barnier’s Administration Confronts Unprecedented No-Confidence Vote
Jaguar Unveils Electric Concept Car, Type 00
White House Defends Presidential Pardon of Hunter Biden
xAI by Elon Musk: Transforming Ambition with a $50 Billion Valuation
President-elect Donald Trump, has announced on Truth Social that Kashyap "Kash" Patel, will be the next Director of the FBI
A Historic Milestone or Risky Precedent? The Assisted Dying Bill Splits both Parliament and the Nation in England and Wales
Trump's Tariff Threat Looms Large as Trudeau Heads to Mar-a-Lago for Talks
×